Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Gene Therapy Market From 2025 to 2029?

The market size for vasopressin has seen a significant increase in recent times. It is projected to escalate from $1.38 billion in 2024 to $1.57 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.7%. The past growth in this sector can be credited to factors such as an ageing population, advancements in hospital and healthcare infrastructure, a rising occurrence of autonomic dysreflexia, better awareness among medical practitioners, and a high incidence of chronic diseases.

Over the coming years, rapid expansion is forecasted for the vasopressin market. The market size is projected to reach “$2.59 billion in 2029,” growing at a compound annual growth rate (CAGR) of “13.3%”. This growth in the forecast period can be credited to an increase in the prevalence of diabetes insipidus, advancements in medication delivery systems, improved understanding and diagnostics, research and development efforts, and a rise in diabetes awareness. Key trends for the forecast period involve technological advancements in manufacturing, innovations in drug formulations and delivery methods, the emergence of personalized multimodal treatment as a new therapeutic approach, a focus on health and wellness, and the prioritization of personalization and customization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16207&type=smp

What Elements Are Contributing To Growth In The Gene Therapy Market?

There has been a substantial uptick in cases of cancer and other such critical diseases, necessitating the need for potent treatment methods and fuels the growth of the gene therapy market. The global escalation in cancer incidence is projected to influence gene therapy market expansion in the upcoming period. For example, the American Cancer Society provided data in January 2022, suggesting that there will probably be 1.9 million new cancer diagnoses and an estimated 609,360 cancer-related fatalities in the US, which is approximately 1,670 deaths on daily basis. The four cancers that are most commonly diagnosed worldwide – lung, prostate, bowel, and female breast cancer, make up for about 43 percent of all newly diagnosed cancer cases worldwide. Thus, the global surge in cancer occurrence is expected to stimulate demand in the gene therapy market in the near future. Gene therapy, which involves the introduction of new genes into cancerous cells or nearby tissue to provoke cell death or reduce cancer growth, is a highly effective treatment in oncology.

The vasopressin market covered in this report is segmented –

1) By Product Type: Intravenous Injection, Intramuscular Injection, Subcutaneous Injection

2) By Application: Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding, Ventricular Tachycardia And Fibrillation

3) By End-User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Intravenous Injection: Standard Iv Vasopressin Injection, High-Dose Iv Vasopressin Injection, Iv Vasopressin For Sepsis And Shock Treatment, Iv Vasopressin For Post-Operative Care

2) By Intramuscular Injection: Standard Im Vasopressin Injection, Intramuscular Vasopressin For Hormonal Imbalance, Vasopressin Injection For Acute Hemorrhage Control

3) By Subcutaneous Injection: Subcutaneous Vasopressin For Diabetes Insipidus, Vasopressin Injection For Fluid Retention Treatment, Long-Acting Subcutaneous Vasopressin Formulations

What Upcoming Trends Are Expected To Impact The Gene Therapy Market Globally?

Leading entities in the vasopressin market are advancing their product offerings through innovation, for instance, by producing pre-mix ready-to-use (RTU) injection bottles. This move is aimed at improving user-friendliness, ensuring accurate dosage, and minimizing the risk of preparation mistakes and possible contamination. Pre-mix RTU injection bottles have emerged as a significant breakthrough in the pharmaceutical sector, particularly for drugs like vasopressin. In a recent development in February 2022, Endo International plc, a pharmaceutical corporation based in the US, introduced a ready-to-use 100 mL pre-mix version of VASOSTRICT (vasopressin injection, USP). This is the debut and sole ready-to-use format of the medicine. The innovative VASOSTRICT product has a shelf-life of two years and can withstand ambient temperatures for a year, thereby enhancing inventory control alongside other advantages offered by its ready-to-use nature. The product is supplied in the form of a virtually colorless, clear solution for IV administration and is available in single-dose vials of 20 units per mL and multi-dose vials of 200 units per 10 mL (20 units per mL).

Who Are The Key Contributors To Growth In The Gene Therapy Market?

Major companies operating in the vasopressin market are Pfizer Inc., Merck KGaA, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Apotex Inc., Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals Inc., Ferring Pharmaceuticals, Amphastar Pharmaceuticals Inc., Bachem Holding AG, Eagle Pharmaceuticals Inc., Par Pharmaceutical Holdings Inc., Athenex Inc., Soho-Yiming Pharmaceuticals Co. Ltd., Nordic Pharma Inc., Cumberland Pharmaceuticals Inc., Laboratorio ELEA S.A.C.I.F. y A., Fresenius Kabi Canada Ltd., AMOMED Pharma GmbH, BCN Peptides SA, Hainan Zhonghe Pharmaceutical Co. Ltd., Denovo Biopharma LLC

https://www.thebusinessresearchcompany.com/report/vasopressin-global-market-report

Which Region Is Projected To Lead The Gene Therapy Market By 2025?

North America was the largest region in the vasopressin market in 2024. The regions covered in the vasopressin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16207&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model